A Milestone Anniversary in Bulgaria Our mission has always been to provide families worldwide with access to the most advanced regenerative medicine and cord blood banking technologies. This month, we are delighted to celebrate a significant milestone in that...
Key details Current treatment limitations: While ischaemic strokes – which account for nearly 90% of all strokes – are currently treated with clot removal and supportive rehabilitation, there remains a significant unmet need for therapies that directly address...
Key details Understanding Lesch-Nyhan syndrome: This rare, recessive condition linked to the X chromosome primarily affects boys, and is characterised by a deficiency of the HPRT enzyme, leading to severe motor dysfunction, uric acid overproduction, and compulsive...
Today is World Cord Blood Day! A lot of progress has been made since the very first cord blood transplant was performed in 1988, 37 years ago. Since then, over 60,000 cord blood transplants have been performed worldwide, and donor cord blood stem cells, such as from a...
A recent study conducted at UMC Utrecht, Netherlands, has shown that mesenchymal stem cells (MSCs) are a safe treatment for brain damage caused by stroke in newborns, and may have a significant positive effect. Perinatal stroke and its consequences Perinatal stroke is...
Stem Cell Therapy Potential for Duchenne Muscular Dystrophy
Long COVID Stem Cell Therapy Expanded Access Programme Wins FDA Approval
Stem Cell Patch May Aid in Spina Bifida Repair in Utero
Stem Cell Therapy Shows Promise for Ageing Frailty
Clinical Trial Explores Placental Stem Cell Gel for Radiotherapy Skin Damage
